Biovaxys Announces Issuance Of Dpx Related Patent From The U.S. Patent And Trademark Office
VANCOUVER, BC, July 23, 2024 - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that...
top of page
bottom of page